Stockscreener 앱 받기
2.65
7.99%
-0.23
시간 외 거래:
2.65
전일 마감가:
$2.88
열려 있는:
$2.77
하루 거래량:
19,089
Relative Volume:
0.31
시가총액:
$62.40M
수익:
-
순이익/손실:
$-12.94M
주가수익비율:
-0.9331
EPS:
-2.84
순현금흐름:
$-13.83M
1주 성능:
-7.99%
1개월 성능:
+40.21%
6개월 성능:
-51.02%
1년 성능:
+68.79%
1일 변동 폭
$2.65
$2.865
1주일 범위:
$2.65
$2.91
52주 변동 폭
$1.01
$7.42
애일러론 테라 Stock (ALRN) Company Profile
명칭
Aileron Therapeutics Inc
전화
(737) 802-1989
주소
12407 N. MOPAC EXPY., AUSTIN, MA
애일러론 테라 Stock (ALRN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-07-24 | 개시 | BofA/Merrill | Buy |
| 2017-07-24 | 개시 | Jefferies | Buy |
| 2017-07-24 | 개시 | William Blair | Outperform |
애일러론 테라 주식(ALRN)의 최신 뉴스
University of Texas Texas AM Investment Management Co. Makes New Investment in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - MarketBeat
Aileron Therapeutics reports voting results from annual meeting - Investing.com
Aileron Therapeutics to Present at the 8th Annual IPF Summit - Citizentribune
ALRN Stock Earnings: Aileron Therapeutics Misses EPS for Q2 2024 - MSN
Aileron Therapeutics to Present at the 8th Annual IPF Summit - PR Newswire
Analysts Issue Forecasts for Aileron Therapeutics, Inc.’s FY2024 Earnings (NASDAQ:ALRN) - Defense World
Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Declines By 12.8% - Defense World
Aileron Therapeutics to Present at the 8th Annual IPF Summit - StockTitan
Aileron Therapeutics (NASDAQ:ALRN) Issues Quarterly Earnings Results - Defense World
Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - Winchester Herald Chronicle
Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - PR Newswire
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - StockTitan
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - Yahoo Finance
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update - Defense World
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Growth in Short Interest - MarketBeat
Aileron Therapeutics Announces Equity Distribution Agreement - Investing.com India
Aileron Therapeutics Announces Equity Distribution Agreement By Investing.com - Investing.com Canada
Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Increases By 94.4% - American Banking and Market News
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update - MarketBeat
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Growth in Short Interest - Defense World
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event - Quantisnow
Imunon (NASDAQ:IMNN) versus Aileron Therapeutics (NASDAQ:ALRN) Head-To-Head Contrast - Defense World
Constrained Peptide Drugs Market Price Trends Analysis Aileron Therapeutics, Inc, Bicycle Therapeutics, PLC ... - Economica
Aileron Therapeutics to be Included in the Russell Microcap® Index - Morningstar
Aileron Therapeutics to be Included in the Russell Microcap® Index - BioSpace
Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Drops By 41.3% - Defense World
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under ... - Quantisnow
How does Aileron Therapeutics Inc (ALRN) change from a tortoise to a hare? – Sete News - SETE News
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Of Texas/Texas Am I. University Sells 4707 Shares - Defense World
University of Texas/Texas A&M sells Aileron Therapeutics shares worth over $21k - Investing.com India
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Of Texas/Texas Am I. University Sells 4,707 Shares - MarketBeat
Natera co-founder Sheena Jonathan sells shares worth over $296k By Investing.com - Investing.com
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 6.9% in May - MarketBeat
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Decrease in Short Interest - Defense World
Of Texas/Texas Am I. University Sells 9342 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - Defense World
Of Texas/Texas Am I. University Sells 9577 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - Defense World
University of Texas/Texas A&M sells Aileron Therapeutics stock - Investing.com India
Of Texas/Texas Am I. University Sells 9,342 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - MarketBeat
University of Texas/Texas A&M sells Aileron Therapeutics stock By Investing.com - Investing.com
TMX Group stock gets PT boost as BMO identifies potential growth catalysts By Investing.com - Investing.com UK
Of Texas/Texas Am I. University Sells 6291 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - Defense World
University of Texas/Texas A&M sells Aileron Therapeutics shares worth over $40k By Investing.com - Investing.com
Insider Selling: Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Sells 6,291 Shares of Stock - MarketBeat
Aileron Therapeutics (NASDAQ:ALRN) & Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Contrast - Defense World
Aileron Therapeutics (NASDAQ:ALRN) Rating Increased to Strong-Buy at Brookline Capital Management - MarketBeat
Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year? - Yahoo Canada Finance
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - br.ADVFN.com
Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year? - Yahoo Finance
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Large Increase in Short Interest - Defense World
Investor's Delight: Aileron Therapeutics Inc (ALRN) Closes Weak at 3.51, Down -4.10 – DWinneX - The Dwinnex
Reviewing Atreca (NASDAQ:BCEL) and Aileron Therapeutics (NASDAQ:ALRN) - Defense World
애일러론 테라 (ALRN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
1.31%
자본화:
|
볼륨(24시간):